ALKS vs CE
Alkermes Plc (ALKS) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CE currently screens at market cap $5.92B.
Not investment advice. Open the ALKS and CE stock pages for the full models.
Not investment advice.